Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bibx 1382bs
2. Bibx-1382bs
3. Bibx1382bs
1. 196612-93-8
2. Bibx 1382
3. Bibx1382
4. Bibx-1382
5. Falnidamol [inn]
6. N8-(3-chloro-4-fluorophenyl)-n2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine
7. Chembl258940
8. 0mu316797d
9. 4-n-(3-chloro-4-fluorophenyl)-6-n-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine
10. Bibx 1382bs
11. 8-(3-chloro-4-fluoroanilino)-2-((1-methyl-4-piperidyl)amino)pyrimido(5,4-d)pyrimidine
12. N4-(3-chloro-4-fluorophenyl)-n6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine
13. Ncgc00161422-01
14. Unii-0mu316797d
15. Falnidamol [who-dd]
16. Bibx-1382bs
17. Bibx-1382bx
18. Schembl158563
19. Gtpl7646
20. Dtxsid0048399
21. Chebi:93243
22. Ex-a570
23. Bcp09515
24. Zinc1494443
25. Bdbm50375639
26. Mfcd09838900
27. Cs-0691
28. Db12966
29. Ncgc00161422-03
30. Ncgc00161422-09
31. Ac-30284
32. As-16894
33. Hy-10322
34. Db-014915
35. Ft-0700465
36. Brd-k70914287-300-01-0
37. Q27077274
38. 8-(3-chloro-4-fluorophenylamino)-2-(1-methylpiperidin-4-ylamino)pyrimido[5,4-d]pyrimidine
39. N-(3-chloro-4-fluorophenyl)-n'-(1-methylpiperidin-4-yl)pyrimido[4,5-e]pyrimidine-4,6-diamine
40. N4-(3-chloro-4-fluoro-phenyl)-n6-(1-methyl-4-piperidyl)pyrimido[5,4-d]pyrimidine-4,6-diamine
41. Pyrimido(5,4-d)pyrimidine-2,8-diamine, N8-(3-chloro-4-fluorophenyl)-n2-(1-methyl-4-piperidinyl)-
| Molecular Weight | 387.8 g/mol |
|---|---|
| Molecular Formula | C18H19ClFN7 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 387.1374495 g/mol |
| Monoisotopic Mass | 387.1374495 g/mol |
| Topological Polar Surface Area | 78.9 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 479 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Falnidamol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Falnidamol, including repackagers and relabelers. The FDA regulates Falnidamol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Falnidamol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Falnidamol supplier is an individual or a company that provides Falnidamol active pharmaceutical ingredient (API) or Falnidamol finished formulations upon request. The Falnidamol suppliers may include Falnidamol API manufacturers, exporters, distributors and traders.
Falnidamol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Falnidamol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Falnidamol GMP manufacturer or Falnidamol GMP API supplier for your needs.
A Falnidamol CoA (Certificate of Analysis) is a formal document that attests to Falnidamol's compliance with Falnidamol specifications and serves as a tool for batch-level quality control.
Falnidamol CoA mostly includes findings from lab analyses of a specific batch. For each Falnidamol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Falnidamol may be tested according to a variety of international standards, such as European Pharmacopoeia (Falnidamol EP), Falnidamol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Falnidamol USP).
LOOKING FOR A SUPPLIER?
